Search Results - Standard Search:"novel coronavirus" OR Covid OR "Sars-CoV" OR "CoV-2" OR ncov

PubPharm (31.105)

1

Trial of COVID-19 Outpatient Treatment in Individuals With Risk Factors for Aggravation : Randomized Trial to Evaluate the Safety and Efficacy of Outpatient Treatments to Reduce the Risk of Worsening in Individuals With COVID-19 With Risk Factors (COVERAGE France)

enthalten in: ClinicalTrials.gov | 2021

2

Unplanned Shifting to Online Distance Learning: Nursing Students' Perception and Achievement : Unplanned Shifting the Traditional Classroom-Based to Online Distance Learning as a Result of (COVID-19) Social Distancing Measures: Nursing Students' Perception and Achievement

enthalten in: ClinicalTrials.gov | 2021

3

Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19 : A Randomised, Double-blind, Placebo-controlled, Phase III Trial to Determine the Efficacy and Safety of Inhaled SNG001 for the Treatment of Patients Hospitalised Due to Moderate COVID-19

enthalten in: ClinicalTrials.gov | 2021

4

Clinical, Functional, Immunological and Genetic Factors on the Severity of the Course of Coronavirus Infection : Assessment of the Influence of Clinical, Functional, Immunological, and Genetic Factors on the Severity of the Course of Coronavirus Infection With SARS-CoV-2 and Post Covid Syndrome

enthalten in: ClinicalTrials.gov | 2021

5

Inhaled Interferon α2b for the Treatment of Coronavirus Disease 19 (COVID-19) : A Phase I/II Randomized, Double-blind, Placebo-controlled Study of Inhaled Interferon α2b for the Treatment of Coronavirus Disease 19 (COVID-19)

enthalten in: ClinicalTrials.gov | 2021

6

Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial : Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial

enthalten in: ClinicalTrials.gov | 2021

7

Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19) : A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of TJ003234 in Subjects With Severe Coronavirus Disease 2019 (COVID-19)

enthalten in: ClinicalTrials.gov | 2021

8

Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19) : A Phase 2b/3, Randomized, Double Blind, Placebo Controlled, Adaptive Design Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19)

enthalten in: ClinicalTrials.gov | 2021

9

Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 Treatment : Clinical Study Evaluating the Efficacy of Chloroquine or Hydroxychloroquine in COVID-19 Treatment

enthalten in: ClinicalTrials.gov | 2021

10

COVID-2019 Testing and Vaccination Among African American and Latinx Public Housing Residents : Multilevel Participatory Intervention to Reduce Barriers and Promote Social and Behavioral Facilitators of COVID-19 Testing Among African Americans and Latinx Public Housing Residents

enthalten in: ClinicalTrials.gov | 2021

1
2
3
4
5
6
7
8
9
10
11
Next »
[3111]